Results 301 to 310 of about 221,455 (333)

Rituximab

2003
Pratik, Multani, Christine A, White
openaire   +2 more sources

Rituximab

Reactions Weekly, 2017
  +5 more sources

Rituximab: an update

Lupus, 2007
openaire   +2 more sources

Retreatment With Rituximab Offers a Similar Survival Benefit as Maintenance Therapy in Patients With Low Tumor Burden Follicular Lymphoma

Ca-A Cancer Journal for Clinicians, 2015
Mary Kay Barton
exaly  

Optimization of Rituximab for the Treatment of DLBCL (I): Dose-Dense Rituximab in the DENSE-R-CHOP-14 Trial of the DSHNHL

Annals of Oncology, 2014
S Zeynalova, V Poeschel, M Hänel
exaly  

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

The Lancet, 2010
M. Hallek, K. Fischer, G. Fingerle-Rowson, A. Fink, R. Busch, J. Mayer, M. Hensel, G. Hopfinger, G. Hess, U. von Grünhagen, Matthias Bergmann, J. Catalano, P. Zinzani, F. Caligaris-cappio, J. Seymour, A. Berrebi, U. Jäger, B. Cazin, M. Trněný, A. Westermann, C. Wendtner, B. Eichhorst, P. Staib, A. Bühler, D. Winkler, T. Zenz, S. Böttcher, M. Ritgen, M. Mendila, M. Kneba, H. Döhner, S. Stilgenbauer   +31 more
semanticscholar   +1 more source

Rituximab

Reactions Weekly, 2021
openaire   +1 more source

Rituximab-Associated Hepatitis B Virus (HBV) Reactivation in Lymphoproliferative Diseases: Meta-Analysis and Examination of FDA Safety Reports

Annals of Oncology, 2011
Yu-Chieh Su, Andrew M Evens, D W Raisch
exaly  

Rituximab

Reactions Weekly, 2015
openaire   +1 more source

Rituximab Maintenance for 2 Years in Patients With High Tumour Burden Follicular Lymphoma Responding to Rituximab Plus Chemotherapy (PRIMA): A Phase 3, Randomised Controlled Trial

Lancet, The, 2011
David A Simpson, René-Olivier Casasnovas, Alain Delmer   +2 more
exaly